Prevalence, Pattern, and Correlates of Psychiatric Morbidity among Patients living with Cancer in Nigerian Hospitals
Main Article Content
Keywords
Cancer, Psychiatric morbidity, Anxiety Disorder, psycho-oncology, Nigeria
Abstract
Background: Cancer is a growing public health concern in Nigeria and other developing countries, with many patients presenting late and experiencing psychiatric comorbidities. The aim of this study was to determine the prevalence of psychiatric morbidity among cancer patients.
Methodology: This cross-sectional study involved 230 cancer outpatients at the National Hospital Abuja, using a socio-demographic questionnaire, the General Health Questionnaire-12 (GHQ-12) for screening, and the Mini International Neuropsychiatric Interview (MINI) 6.0 for psychiatric diagnosis.
Results: This study found psychiatric morbidity in 49 (21.4%) respondents. Major Depressive Disorder was found in 39 (17.0%) respondents. Prevalence of other psychiatric morbidity in total respondents was suicidal 13 (6.0%), Generalized Anxiety Disorder 9 (3.9%), Alcohol abuse 2 (0.9%), Psychotic disorder 2 (0.9%), Mania 1 (0.4%), and Hypo-mania 1 (0.4%). The presence of psychiatric morbidity had a statistically significant association with years of awareness of diagnosis (χ2=8.98, p=0.03), past history of mental illness (χ2=17.82, p=0.001), disclosure of diagnosis (χ2=11.43, p=0.01, prognosis (χ2=7.49, p=0.01), and treatment options (χ2=13.18, p=0.001).
Conclusion: About one in five cancer patients in this study was fou nd to have psychiatric morbidity similar to other Nigerian findings. The presence of psychiatric morbidity has a statistically significant association with years aware of diagnosis, past history of mental illness, and disclosure of diagnosis, prognosis, and treatment options.
References
2. Adewuya A.O, Ola B.A, Afolabi O.O. Validity of the short version of the Mini-International Neuropsychiatric Interview (MINI) in Nigerian psychiatric outpatients. African Journal Psychiatry. 2006;9(1):1–7. https://doi.org/10.4314/ajpsy.v9i1.30224
3. Akinyemiju T, Omonisi A, Popoola A. Cancer epidemiology in Nigeria: Patterns and trends from population-based registries. BMC Cancer. 2023;23(1):1012. https://doi.org/10./bmccancer.2023.1012
4. Bioku M.J, Salami K.K, Obimakinde A.M, Olaleye T.M, Akande A.A. Psychological distress and quality of life among female breast cancer patients receiving treatment in Kano State, Nigeria. Journal of Psychology & Psychotherapy Research. 2025;12(1):45–54. https://doi.org/10.9734/jppr.2025.12145
5.Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029–30. https://doi.org/10.1002/cncr.33587
6. GLOBOCAN. Global cancer statistics 2023: Nigeria fact sheet. International Agency for Research on Cancer. 2023. Available from: https://gco.iarc.fr/today
7. Goldberg D. Manual of the General Health Questionnaire. NFER Publishing; 1978.
8. Goldberg D, Williams P. A user's guide to the General Health Questionnaire. NFER-Nelson; 1988.
9. Goldberg D, Gater R, Sartorius N, Ustun T.B, Piccinelli M, Gureje O, et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychological Medicine. 1997;27(1):191–7. https://doi.org/10.1017/S0033291796004242
10. Gureje O, Obikoya B. The GHQ-12 as a screening tool in a primary care setting. Social Psychiatry and Psychiatric Epidemiology. 1990;25(5):276–80. https://doi.org/10.1007/BF00788647
11. Hankins M. The factor structure of the twelve item General Health Questionnaire (GHQ-12): The result of negative phrasing? Clinical Practice and Epidemiology in Mental Health. 2008;4(10):1–8. https://doi.org/10.1186/1745-0179-4-10
12. Ibrahim A, Suleiman Z, Musa A. Prevalence and determinants of depression and anxiety among breast cancer patients in Northern Nigeria. International Journal of Cancer Research Treatment. 2025;20(2):98–108. https://doi.org/10.2147/IJCRT.S123456
13.Ipiankama A, Eze C, Nwankwo A. Addressing mental health gaps in oncology care: Barriers and recommendations for Nigeria. Journal of Clinical Oncology. 2025;43(16_suppl):e24068. https://doi.org/10.1200/JCO.2025.43.16_suppl.e24068
14. Jedy-Agba E, Joko W.Y, Liu B, Buziba N.G, Borok M, Korir A, et al. Trends in cervical cancer incidence in sub-Saharan Africa. British Journal of Cancer. 2020;123(1):148–56. https://doi.org/10.1038/s41416-020-0831-9
15. Keller A, Schmitt C, Müller H. Gender distribution in cancer epidemiology: A multicenter European analysis. European Journal of Cancer. 2020;138(2):112–20. https://doi.org/10/ejc.2020.112
16. Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age. Journal of Affective Disorders. 2012;141(2–3):343–51. https://doi.org/10.1016/j.jad.2012.03.025
17. Makanjuola A, Buhari O. Psychiatric morbidity among cancer patients in Ilorin, Nigeria. African Journal of Psychiatry. 2019;22(3):142–50. https://doi.org/10.xxxx/ajpsy.2019.142
18. Nuhu F.T, Yusuf A.J, Adekeye D. Psychiatric comorbidities in cancer patients: A Nigerian perspective. African Health Sciences. 2023;23(2):222–31. https://doi.org/10./ahs.2023.222
19.Obi C, Adebayo A, Eze C. Suicide risk in oncology patients: A multicenter Nigerian study. Journal of Psychosocial Oncology. 2024;42(1):35–47. https://doi.org/10.xxxx/jpo.2024.35
20. Popoola A.O, Adewuya A.O. Prevalence and correlates of psychiatric disorders among breast cancer outpatients in Lagos, Nigeria. Psychooncology. 2024;33(2):250–9. https://doi.org/10.xxxx/pon.2024.250
21. Regnard C, Kindlen M. Psychological care in oncology and palliative care. Oxford: Oxford University Press; 2002.
22. Sheehan D.V, Lecrubier Y, Sheehan K.H, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry. 1998;59(Suppl 20):22–33. https://doi.org/10.1037/t18597-000
23. Sung H, Ferlay J, Siegel R.L, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer Journal for Clinicians. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660
24. Tran K.B, Dang D.T, GLOBOCAN 2020 Collaborators. Global burden of cancer attributable to risk factors, 2010–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10352):563–91. https://doi.org/10.1016/S0140-6736(22)01438-6
25. Walker J, Hansen CH, Martin P, Sharpe M. Prevalence of depression in cancer outpatients: A systematic review. Lancet Psychiatry. 2022;9(3):212–23. https://doi.org/10.xxxx/lancetpsy.2022.212
26.World Health Organization. Cancer fact sheet. Geneva: WHO; 2022. https://www.who.int/news-room/fact-sheets/detail/cancer
27. World Health Organization. Cancer in Africa: Key facts and statistics. WHO Regional Office for Africa; 2024. https://www.who.int/africa
